Literature DB >> 23181003

Moving beyond guidelines to ensure high-quality cancer care in the United States.

Karl Y Bilimoria1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23181003      PMCID： PMC3396834          DOI： 10.1200/JOP.2012.000686

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  13 in total

1.  Achieving and sustaining improved quality: lessons from New York State and cardiac surgery.

Authors:  Mark R Chassin
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Aug       Impact factor: 6.301

2.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

3.  Medicare's public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions.

Authors:  Andrew M Ryan; Brahmajee K Nallamothu; Justin B Dimick
Journal:  Health Aff (Millwood)       Date:  2012-03       Impact factor: 6.301

Review 4.  Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.

Authors:  Sandra L Wong; Charles M Balch; Patricia Hurley; Sanjiv S Agarwala; Timothy J Akhurst; Alistair Cochran; Janice N Cormier; Mark Gorman; Theodore Y Kim; Kelly M McMasters; R Dirk Noyes; Lynn M Schuchter; Matias E Valsecchi; Donald L Weaver; Gary H Lyman
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

5.  Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.

Authors:  Janice N Cormier; Yan Xing; Meichun Ding; Jeffrey E Lee; Paul F Mansfield; Jeffrey E Gershenwald; Merrick I Ross; Xianglin L Du
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

6.  Receipt of appropriate surgical care for Medicare beneficiaries with cancer.

Authors:  Caprice C Greenberg; Stuart R Lipsitz; Bridget Neville; Haejin In; Nathanael Hevelone; Stacy A Porter; Christine Weeks; Ashish K Jha; Atul A Gawande; Deborah Schrag; Jane C Weeks
Journal:  Arch Surg       Date:  2011-06-20

7.  Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables.

Authors:  Jennifer L Erickson; Josè M Velasco; Tina J Hieken
Journal:  Ann Surg Oncol       Date:  2008-02-01       Impact factor: 5.344

8.  Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.

Authors:  Karl Y Bilimoria; Charles M Balch; David J Bentrem; Mark S Talamonti; Clifford Y Ko; Julie R Lange; David P Winchester; Jeffrey D Wayne
Journal:  Ann Surg Oncol       Date:  2008-04-15       Impact factor: 5.344

9.  National assessment of melanoma care using formally developed quality indicators.

Authors:  Karl Y Bilimoria; Mehul V Raval; David J Bentrem; Jeffrey D Wayne; Charles M Balch; Clifford Y Ko
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

Review 10.  Systematic review: the evidence that publishing patient care performance data improves quality of care.

Authors:  Constance H Fung; Yee-Wei Lim; Soeren Mattke; Cheryl Damberg; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391
View more
  1 in total

1.  The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates.

Authors:  Antonella Vecchiato; Simone Mocellin; Paolo Del Fiore; Giulio Tosti; Paolo A Ascierto; Maria Teresa Corradin; Vincenzo De Giorgi; Giuseppe Giudice; Paola Queirolo; Caterina Ferreli; Marcella Occelli; Monica Giordano; Giusto Trevisan; Luigi Mascheroni; Alessandro Testori; Romina Spina; Alessandra Buja; Francesco Cavallin; Corrado Caracò; Antonio Sommariva; Carlo Riccardo Rossi
Journal:  BMC Cancer       Date:  2021-01-05       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.